View our latest research stories.

January 11, 2024 Policy Watch

Using Financial Incentives to Treat Stimulant Use Disorders

Stimulants are involved in a substantial and growing percentage of the more than 100,000 overdose deaths in the United States each year. Methamphetamine and cocaine are increasingly present in overdoses involving fentanyl—fueling what has been called the “fourth wave” of the opioid overdose crisis. Unlike opioid use disorder, there are no FDA-approved medications to treat […]

August 23, 2023 Policy Watch

Many State Medicaid Programs Still Require Prior Authorization for Buprenorphine Treatment for Opioid Use Disorder

The opioid epidemic has been an ongoing public health crisis in the United States, claiming countless lives and devastating communities. Buprenorphine, a highly effective medication for the treatment of opioid use disorders, holds the potential to save lives. However, a significant hurdle exists in the form of prior authorization requirements, which are associated with lower access to […]

August 22, 2023 Policy Watch

LDI Experts Analyze the New U.S. Plan to Target Xylazine-Laced Fentanyl

The lethal mixture of xylazine and fentanyl, also known as Tranq dope, may sound unfamiliar to many, but its impact is harming people who use drugs nationwide. Xylazine, approved by the U.S. Food and Drug Administration for veterinary use as a sedative, has become a major component in the illicit drug trade. When consumed by humans, xylazine causes […]

August 4, 2023 Research Highlights

Initiation of Hepatitis C Treatment Low Among Medicaid Recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus. The findings revealed that treatment uptake rates were even lower among people under 30, women, […]

August 2, 2023 Profile Feature

Intern Spotlight: Valeria Arango, Benicio Beatty, Ameya Komaragiri, Carlos Ponce de Leon Mendez, and Ella Salim

During the peak hour of a July summer day, CHERISH colleagues and interns from Boston Medical Center logged onto Zoom while investigators and staff in New York City filled a conference room located on the Upper East Side at Weill Cornell Medicine. Three minutes past twelve, Caroline Savitsky, program manager in the Section of Infectious […]

July 26, 2023 Profile Feature

CHERISH Welcomes Pilot Grant Recipients to Advance the Treatment of Substance Use Disorders, HCV, and HIV

Meet the ninth cohort of early-career investigators from the states of California, Texas, and Washington. CHERISH awarded each investigator up to $20,000 for a pilot study that focuses on conducting health economics research in substance use, hepatitis C virus (HCV), and HIV. This year, CHERISH also encouraged applicants to integrate drug overdose prevention, the syndemics […]

a man wearing a volunteer shirt talks to a seated person at eye-level
July 11, 2023 Research Highlights

Economic benefits of substance use disorder treatment: A systematic literature review of economic evaluation studies from 2003 to 2021

The economic burden of substance use disorder (SUD) is significant. It encompasses clinical and societal costs such as health care and social services, criminal justice resources, loss of productivity, and premature mortality, and is estimated to cost more than $700 billion per year in the United States. To understand the gravity of these economic costs, […]

April 5, 2023 Collaborations

Penn LDI & CHERISH Launch New Online Communications Training Course for Academic Researchers

The University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), which since 2019 has been offering the Amplify[at] LDI in-person communications course to help academic researchers translate and disseminate their findings more widely, has developed and just launched a free, online course providing an introduction to the same topics. The new training resource is […]

March 2, 2023 Profile Feature

Dr. Yuhua Bao Receives Grants to Study Implications of Opioid and Other Drug Policies on People with Cancer

Dr. Yuhua Bao, professor of population health sciences in the Division of Health Policy and Economics, has received grants from the American Cancer Society (ACS) and the National Cancer Institute (NCI) to assess the implications of opioid and other drug policies for patients receiving active cancer treatments, long-term survivors of cancer, and cancer patients with advanced disease. “Both studies are motivated by the […]

March 2, 2023 Profile Feature

Sean M. Murphy and Chelsea L. Shover Receive Inaugural NIH HEAL Director’s Award and Trailblazer Award

The 4th Annual NIH Helping to End Addiction Long-Term (HEAL) Initiative Investigator Meeting took place on February 22, 2023. HEAL-funded investigators and key stakeholders gathered in Bethesda, MD, to share research findings and identify new opportunities for pain and opioid use disorder research. HEAL Director Dr. Rebecca Baker also presented the inaugural NIH HEAL Initiative Director’s Awards for […]

February 16, 2023 Policy Watch

Will States and Counties Spend Their National Opioid Settlements Effectively?

As $54 billion in National Opioid Settlement funds begin moving out toward states, counties, and municipalities, there is widespread concern among health authorities that the legal victory does not become a repeat of the 1998 mega-billion-dollar Tobacco Master Settlement Agreement fiasco in which most states used the money for just about everything except tobacco cessation […]

February 9, 2023 Policy Watch

New Federal Rules That Lower Barriers to Opioid Care Could Save Thousands of Lives

The two main medications that treat opioid use in the United States reduce overdose deaths by 50%. Yet fewer than one in 10 people with opioid use disorder (OUD) can access this kind of medical protocol, according to the Centers for Disease Control and Prevention (CDC). Fortunately, a new law and a new federal regulation […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.